SEC Form 4 · accession 0001140361-15-042807
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne Reiser
Officer — President - ResMed Europe
Period of report
Nov 20, 2015
Accepted (ET)
Nov 24, 2015 · 8:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Nov 20, 2015 | M | 3,400 | $20.355 | A | 79,700 | D | |
| ResMed Common StockF2 | Nov 20, 2015 | S | 3,400 | $59.021 | D | 76,300 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF1 | $20.355 | Nov 20, 2015 | M | 3,400 | D | Feb 23, 2009 | Feb 23, 2016 | ResMed Commmon Stock | 3,400 | 3,000 | D |
Explanation of responses
- F1Represents date options first became exercisable. Options vest 1/4 each year on the anniversary of the grant.
- F2This transaction was executed in multiple trades at prices ranging from $59.01 to $59.07. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.